Literature DB >> 12817045

Percutaneous osteoplasty as a treatment for painful malignant bone lesions of the pelvis and femur.

Johannes Hierholzer1, Gianni Anselmetti, Heiko Fuchs, Claude Depriester, Karin Koch, Dirk Pappert.   

Abstract

The purposes of this report are to describe percutaneous osteoplasty as a highly effective minimally invasive procedure to treat painful malignant bone lesions of the pelvis, ilium, and femur and to discuss the relevant literature. Five patients with histologically proven metastases to the pelvis, ilium, or femur were treated by percutaneous injection of liquid bone cement as an attempt to control severe bone pain. After percutaneous osteoplasty, all five patients experienced immediate and substantial pain relief and did not require pain medication for the duration of follow-up. No clinically significant complications occurred. Whereas percutaneous osteoplasty of the spine (vertebroplasty) is well-described and widely accepted to treat pain caused by benign or malignant vertebral body diseases, osteoplasty of bones outside the spine is less known. The immediate good clinical results observed in our small patient group should encourage more widespread application of this palliative treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817045     DOI: 10.1097/01.rvi.0000079987.80153.85

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  32 in total

1.  [Guidelines of the German Radiological Society for percutaneous vertebroplasty].

Authors:  T Helmberger; K Bohndorf; J Hierholzer; G Nöldge; D Vorwerk
Journal:  Radiologe       Date:  2003-09       Impact factor: 0.635

Review 2.  Interventional MSK procedures: the hip.

Authors:  Emilie Dodré; Guillaume Lefebvre; Eric Cockenpot; Patrick Chastanet; Anne Cotten
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

Review 3.  Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Thomas D Atwell; Michael A Farrell; Timothy J Welch; Timothy P Maus
Journal:  Skeletal Radiol       Date:  2005-10-05       Impact factor: 2.199

4.  Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine.

Authors:  Giovanni Carlo Anselmetti
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

5.  Percutaneous cementoplasty for painful osteolytic humeral metastases: initial experience with an innovative technique.

Authors:  Gang Sun; Peng Jin; Min Li; Yang Lu; Jun Ding; Xunwei Liu; Fandong Li
Journal:  Skeletal Radiol       Date:  2011-04-15       Impact factor: 2.199

6.  Cementoplasty of pelvic bone metastases: systematic assessment of lesion filling and other factors that could affect the clinical outcomes.

Authors:  Thomas P Moser; Marta Onate; Katia Achour; Véronique Freire
Journal:  Skeletal Radiol       Date:  2019-02-02       Impact factor: 2.199

7.  Percutaneous reinforced osteoplasty for long bone metastases: a feasibility study.

Authors:  Nischal Koirala; Gordon McLennan
Journal:  Skeletal Radiol       Date:  2019-08-04       Impact factor: 2.199

8.  Percutaneous imaging-guided ablation therapies in the treatment of symptomatic bone metastases: preliminary experience.

Authors:  G Carrafiello; D Laganà; C Pellegrino; F Fontana; M Mangini; P Nicotera; M Petullà; E Bracchi; E Genovese; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2009-05-14       Impact factor: 3.469

9.  Percutaneous osteoplasty for painful sternal lesion from multiple myeloma.

Authors:  Bing Zhou; Chun-Gen Wu; Ming-Hua Li; Yi-Feng Gu; Yong-De Cheng
Journal:  Skeletal Radiol       Date:  2008-12-03       Impact factor: 2.199

10.  Percutaneous osteoplasty for the management of a femoral head metastasis: a case report.

Authors:  Wei-Guo Wang; Chun-Gen Wu; Yi-Feng Gu; Ming-Hua Li
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.